---
$id: https://graph.org.ai/products/commodity/51142408
$type: Product
source: UNSPSC
code: "51142408"
title: "Frovatriptan"
class: "51142400"
classTitle: "Drugs used for vascular and migraine headaches"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Frovatriptan

**UNSPSC Code**: 51142408
**Class**: [Drugs used for vascular and migraine headaches](Drugs used for vascular and migraine headaches.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a serotonin agonist with the molecular formula C14H17N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H82Q2D5WA7, chemically known as 6-methylamino-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide but generally known as frovatriptan, which bears US NIH Compound Identifier 77992. European Medicines Agency schedules Frovatriptan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07817MIG. The term FROVATRIPTAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). World Health Organization schedules frovatriptan in its Anatomical Therapeutic Chemical (ATC) Classification. FROVATRIPTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule frovatriptan under HS 29339990 and SITC 51577. As of Q4 2014, FROVATRIPTAN remains the US FDA Preferred Term for this commodity. Frovatriptan bears US NLM identifiers UMLS ID C0754647 and NCI Concept Code C65772. SMILES: O=C(N)C1CC2C3CC(NC)CCC3[NH]C2CC1.

